ResearcherTianjin Medical University Cancer Institute and HospitalNo recent work listed
Manman Quan
Matched on OpenAlex author ID A5023186978. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2016: 1 paper · 2017: 1 paper · 2018: 1 paper
Papers 3
- Systemic chemotherapy in combination with liver-directed therapy improves survival in patients with pancreatic adenocarcinoma and synchronous liver metastases. Co-author DOI 10.1016/j.pan.2018.09.015↗
- Factors influencing survival of patients with pancreatic adenocarcinoma and synchronous liver metastases receiving palliative care. Co-author DOI 10.1016/j.pan.2017.07.002↗
- [Multidisciplinary treatment and survival analysis for 497 cases of pancreatic cancer with liver metastases]. Last author DOI 10.3760/cma.j.issn.0376-2491.2016.06.003↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Huaqiang Ouyang · 3 shared papers, 2016–2018 · strength 0.23
- Paper Systemic chemotherapy in combination with liver-directed therapy improves survival in patients with pancreatic adenocar… DOI 10.1016/j.pan.2018.09.015↗
- Paper Factors influencing survival of patients with pancreatic adenocarcinoma and synchronous liver metastases receiving pall… DOI 10.1016/j.pan.2017.07.002↗
- Paper [Multidisciplinary treatment and survival analysis for 497 cases of pancreatic cancer with liver metastases]. DOI 10.3760/cma.j.issn.0376-2491.2016.06.003↗
- Weidong Ma · 2 shared papers, 2017–2018 · strength 0.16
- Paper Systemic chemotherapy in combination with liver-directed therapy improves survival in patients with pancreatic adenocar… DOI 10.1016/j.pan.2018.09.015↗
- Paper Factors influencing survival of patients with pancreatic adenocarcinoma and synchronous liver metastases receiving pall… DOI 10.1016/j.pan.2017.07.002↗
- Zhanyu Pan · 2 shared papers, 2017–2018 · strength 0.16
- Paper Systemic chemotherapy in combination with liver-directed therapy improves survival in patients with pancreatic adenocar… DOI 10.1016/j.pan.2018.09.015↗
- Paper Factors influencing survival of patients with pancreatic adenocarcinoma and synchronous liver metastases receiving pall… DOI 10.1016/j.pan.2017.07.002↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.